logo
15:57 Mar 16

Syncom Formulation (India) Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals
Up
11.82
-0.24 (-1.99%)
Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

Syncom Formulation (India) Ltd. Financials

Syncom Formulation (India) Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Up
11.82
-0.24 (-1.99%)
15:57 Mar 16
Quality
image/svg+xml

86/100
High Financial Strength

Valuation
image/svg+xml

45/100
Mid Valuation

Technical

28/100
Technically Bearish

Strength

14

Weakness

5

Opportunity

1

Threats

0

14.44 %

ROE %

11.96 %

ROA %

0.73

EPS

3.64

BVPS

10.63 %

Net Profit Margin

Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM 2025
Net Sales
219.66 224.25 263.39 465.01 502.64
Operating Expenses +
199.62 204.62 233.75 410.89 429.45
Raw Material
137.22 142.07 158.64 318 296.12
Increase Decrease in Cost
3.32 -0.38 -1.75 -10.66 5.21
Other Manufacturing Expense
6.31 8.15 8.12 8.1 0
Employee Cost
22.16 25.87 35.06 52.17 65.1
Miscellaneous Expenses
110.23 114.13 87.9 123.22 63.02
Operating Profit
20.04 19.63 29.64 54.12 73.19
Other Income
11.99 14.6 13.53 17.43 23.72
Depreciation
3.95 4.54 4.72 5.19 5.34
Interest
1.93 3.13 4.47 0.86 0.89
Profit before tax and exceptio..
26.15 26.56 33.98 65.51 90.68
Exceptional Items
0.02 0.01 -0.02 0.01 0.05
PBT
26.18 26.57 33.95 65.51 90.63
Provision for Taxation
6.39 6.5 8.64 16.08 21.77
Net Profit
19.79 20.07 25.31 49.43 68.95
NET Profit after MI
19.79 20.07 25.31 49.43 68.95
EPS
0.26 0.24 0.34 0.57 0.78
Operating Profit Margin (%)
9.12 8.75 11.25 11.64 14.56
Net Profit Margin (%)
9.01 8.95 9.61 10.63 13.72

Syncom Formulation (India) Ltd. Shareholding

All Data in Percentage (%)
Promoter - - - - -
FII - - - - -
Public - - - - -
MF - - - - -
Others
Shareholder Shares Holding %
Research 360 logo
Download Our App On: